Nitroxyl Improves Cellular Heart Function by Directly Enhancing Cardiac Sarcoplasmic Reticulum Ca2+ Cycling

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Circulation Research

• Publication date

  2007-01-05

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1161/01.RES.0000253904.53601.c9PMID 17138943PMCID PMC2769513
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Compartmentalized Phosphodiesterase-2 Activity Blunts &bgr;-Adrenergic Cardiac Inotropy via an NO/cGMP-Dependent Pathway

  2006cited by this paper
• Cross-linking of C-terminal Residues of Phospholamban to the Ca2+ Pump of Cardiac Sarcoplasmic Reticulum to Probe Spatial and Functional Interactions within the Transmembrane Domain*

  2006cited by this paper
• The physiological chemistry and biological activity of nitroxyl (HNO): the neglected, misunderstood, and enigmatic nitrogen oxide.

  2005cited by this paper
• Inhibition of yeast glycolysis by nitroxyl (HNO): mechanism of HNO toxicity and implications to HNO biology.

  2005cited by this paper
• Abnormal intrastore calcium signaling in chronic heart failure.

  2005cited by this paper
• Phospholamban: a key determinant of cardiac function and dysfunction.

  2005cited by this paper
• The control of sarcoplasmic reticulum Ca content in cardiac muscle.

  2005cited by this paper
• Calcitonin Gene-Related Peptide In Vivo Positive Inotropy Is Attributable to Regional Sympatho-Stimulation and Is Blunted in Congestive Heart Failure

  2005cited by this paper
• IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW，Thompson RW，et al//Proc Natl Acad Sci U S A

  2005cited by this paper
• The Ryanodine Receptors Ca2 + Release Channels: Cellular Redox Sensors?

  2005cited by this paper
• Caffeine-induced arrhythmias in murine hearts parallel changes in cellular Ca(2+) homeostasis.

  2005cited by this paper
• Mechanisms and models in heart failure: the biomechanical model and beyond.

  2005cited by this paper
• Nitroxyl triggers Ca2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors.

  2005cited by this paper
• Regulation of the mammalian heart function by nitric oxide.

  2005cited by this paper
• A mitochondrial oscillator dependent on reactive oxygen species.

  2004cited by this paper
• Positive inotropic and lusitropic effects of HNO/NO− in failing hearts: Independence from β-adrenergic signaling

  2003cited by this paper
• Is depressed myocyte contractility centrally involved in heart failure?

  2003cited by this paper
• Abnormal Ca2+ Release, but Normal Ryanodine Receptors, in Canine and Human Heart Failure

  2002cited by this paper
• Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery

  2002cited by this paper
• Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure.

  2001cited by this paper
• Nitroxyl anion regulation of the NMDA receptor

  2001cited by this paper
• Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling

  2001cited by this paper
• Positive and negative effects of nitric oxide on Ca(2+) sparks: influence of beta-adrenergic stimulation.

  2001cited by this paper
• Positive and negative effects of nitric oxide on Ca2+ sparks: influence of β-adrenergic stimulation

  2001cited by this paper
• Arginine Conversion to Nitroxide by Tetrahydrobiopterin-free Neuronal Nitric-oxide Synthase

  2000cited by this paper
• PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

  2000cited by this paper
• Recent advances in cardiac beta(2)-adrenergic signal transduction.

  1999cited by this paper
• Recent Advances in Cardiac b2-Adrenergic Signal Transduction

  1999cited by this paper
• Kinetic Differences in the Phospholamban-Regulated Calcium Pump When Studied in Crude and Purified Cardiac Sarcoplasmic Reticulum Vesicles

  1999cited by this paper
• Constitutive β2‐adrenergic signalling enhances sarcoplasmic reticulum Ca2+ cycling to augment contraction in mouse heart

  1999cited by this paper
• Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO-.

  1999cited by this paper
• Amplitude distribution of calcium sparks in confocal images: theory and studies with an automatic detection method.

  1999cited by this paper
• Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation.

  1998cited by this paper
• Termination of Ca2+ release by a local inactivation of ryanodine receptors in cardiac myocytes.

  1998cited by this paper
• Inactivation of the cardiac ryanodine receptor calcium release channel by nitric oxide.

  1997cited by this paper
• Nitric oxide activates skeletal and cardiac ryanodine receptors.

  1997cited by this paper
• No .NO from NO synthase.

  1996cited by this paper
• Phosphorylation Modulates the Function of the Calcium Release Channel of Sarcoplasmic Reticulum from Cardiac Muscle (*)

  1995cited by this paper
• Na-Ca exchange is required for rest-decay but not for rest-potentiation of twitches in rabbit and rat ventricular myocytes.

  1994cited by this paper
• Detection of angiotensin I and II in cultured rat cardiac myocytes and fibroblasts.

  1992cited by this paper
• Studies of sarcoplasmic reticulum function and contraction duration in young adult and aged rat myocardium.

  1978cited by this paper
• Adenosine 3':5'-monophosphate-dependent protein kinase-catalyzed phosphorylation reaction and its relationship to calcium transport in cardiac sarcoplasmic reticulum.

  1974cited by this paper

• Electronic Modification of a Reduced Mononuclear Nonheme Iron Nitrosyl Complex Leads to HNO Release.

  2025cites this paper
• Oxidative HNO Formation Mechanisms from NH2OH via Two Different Heme Proteins and Effects from Hemes, Nearby Residues, and Protein Environments

  2025cites this paper
• Salivary-Gland-Mediated Nitrate Recirculation as a Modulator for Cardiovascular Diseases

  2025cites this paper
• Oxidative and Hydrolytic HNO Formation from a Clinical Drug Hydroxyurea Catalyzed by Horseradish Peroxidase: Basic Mechanism, Active Site Effect, and Implications for Drug Design

  2025cites this paper
• Nitroxyl donating and visualization with a coumarin-based fluorescence probe.

  2024cites this paper
• Expanding the Frontiers of Guardian Antioxidant Selenoproteins in Cardiovascular Pathophysiology

  2024cites this paper
• Azobenzene-based colorimetric and fluorometric chemosensor for nitroxyl releasing.

  2024cites this paper
• Rodlet Cells Provide First Line of Defense against Swimbladder Nematode and Intestinal Coccidian in Anguilla anguilla

  2023cites this paper
• Endogenous plant nitroxyl, a new component of nitric oxide biology.

  2023cites this paper
• Targeting calcium regulators as therapy for heart failure: focus on the sarcoplasmic reticulum Ca-ATPase pump

  2023cites this paper
• Reactive Oxygen Species Induced Pathways in Heart Failure Pathogenesis and Potential Therapeutic Strategies

  2022cites this paper
• A bifunctional fluorescent probe based on "AND logic" for the simultaneous recognition of H2S/HNO and its bioimaging applications.

  2022cites this paper
• Effects of intestinal bacteria on cardiovascular disease

  2022cites this paper
• Melatonin, Its Metabolites and Their Interference with Reactive Nitrogen Compounds

  2021cites this paper
• Oxidative stress in early metabolic syndrome impairs cardiac RyR2 and SERCA2a activity and modifies the interplay of these proteins during Ca2+ waves

  2021cites this paper
• Interaction among Hydrogen Sulfide and Other Gasotransmitters in Mammalian Physiology and Pathophysiology.

  2021cites this paper
• Nitroaromatic Antibiotics as Nitrogen Oxide Sources

  2021cites this paper
• Solid-gas reactions for nitroxyl (HNO) generation in the gas phase.

  2021cites this paper
• A novel dansyl-naphthalimide fluorescent probe for visualizing nitroxyl (HNO) in biological systems

  2021cites this paper
• Rad Modulation of the L-type Calcium Channel Confers Systolic Advantage in the Heart

  2021cites this paper
• Novel approaches to the management of chronic systolic heart failure: future directions and unanswered questions.

  2020cites this paper
• Nitroxyl: A Novel Strategy to Circumvent Diabetes Associated Impairments in Nitric Oxide Signaling

  2020cites this paper
• Systolic Dysfunction in Heart Failure

  2020cites this paper
• Updating NO•/HNO interconversion under physiological conditions: A biological implication overview.

  2020cites this paper
• Mechanisms Associated to Nitroxyl (HNO)-Induced Relaxation in the Intestinal Smooth Muscle

  2020cites this paper
• Nitroxyl as a Potential Theranostic in the Cancer Arena

  2020cites this paper
• Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study.

  2020cites this paper
• Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology.

  2020cites this paper
• Date and Place of Birth

  2020cites this paper
• Receptor-independent modulation of cAMP-dependent protein kinase and protein phosphatase signaling in cardiac myocytes by oxidizing agents

  2020cites this paper
• Nitric oxide donors as potential drugs for the treatment of vascular diseases due to endothelium dysfunction.

  2020cites this paper
• In vivo effects of nitrosyl hydrogen on cardiac function and sarcoplasmic reticulum calcium pump (SERCA2a) in rats with heart failure after myocardial infarction.

  2020cites this paper
• Cardiovascular Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO•) and Nitroxyl (HNO), in the Setting of Reactive Oxygen Species Dysregulation.

  2020cites this paper
• Nitric Oxide Resistance, Induced in the Myocardium by Diabetes, Is Circumvented by the Nitric Oxide Redox Sibling, Nitroxyl

  2020influential citation
• Treatments targeting inotropy A position paper of the Committees on Translational Research and Acute Heart Failure of the Heart Failure Association of the European Society of Cardiology

  2019cites this paper
• Hurdles to Cardioprotection in the Critically Ill

  2019cites this paper
• Incubation with sodium nitrite attenuates fatigue development in intact single mouse fibres at physiological PO2

  2019cites this paper
• A Mononuclear, Nonheme FeII-Piloty's Acid (PhSO2NHOH) Adduct: An Intermediate in the Production of {FeNO}7/8 Complexes from Piloty's Acid.

  2019cites this paper
• Tracking nitroxyl-derived posttranslational modifications of phospholamban in cardiac myocytes

  2019influential citation
• Advances in research on treatment of heart failure with nitrosyl hydrogen

  2019cites this paper
• An isophorone-fused near-infrared fluorescent probe with a large Stokes shift for imaging endogenous nitroxyl in living cells and zebrafish.

  2019cites this paper
• A 6-acetyl-2-naphthol based two-photon fluorescent probe for the selective detection of nitroxyl and imaging in living cells

  2019cites this paper
• A Phase 1 Randomized Study of Single Intravenous Infusions of the Novel Nitroxyl Donor BMS‐986231 in Healthy Volunteers

  2019cites this paper
• Leveraging Signaling Pathways to Treat Heart Failure With Reduced Ejection Fraction.

  2019cites this paper
• Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure

  2019cites this paper
• Nitroxyl (HNO) targets phospholamban cysteines 41 and 46 to enhance cardiac function

  2019cites this paper
• NO and HNO donors, nitrones, and nitroxides: Past, present, and future

  2018cites this paper
• Development of Photoactivatable Nitroxyl (HNO) Donors Incorporating the (3‐Hydroxy‐2‐naphthalenyl)methyl Phototrigger

  2018cites this paper
• A recent history of nitroxyl chemistry, pharmacology and therapeutic potential

  2018cites this paper
• A Chemiluminescent Probe for HNO Quantification and Real-Time Monitoring in Living Cells.

  2018cites this paper
• Treatments targeting inotropy.

  2018cites this paper
• Furthering the understanding of the redox control of soluble epoxide hydrolase and protein kinase G in the cardiovascular system

  2018cites this paper
• Nitric oxide signalling in cardiovascular health and disease

  2018cites this paper
• Development and cellular application of visible-light-controllable HNO releasers based on caged Piloty's acid.

  2018cites this paper
• Intravenous Infusion of the Novel HNO Donor BMS-986231 Is Associated With Beneficial Inotropic, Lusitropic, and Vasodilatory Properties in 2 Canine Models of Heart Failure

  2018cites this paper
• The Anti-Cancer Multikinase Inhibitor Sorafenib Impairs Cardiac Contractility by Reducing Phospholamban Phosphorylation and Sarcoplasmic Calcium Transients

  2018cites this paper
• HNO–Thiol Relationship

  2017cites this paper
• Detection of HNO by Membrane Inlet Mass Spectrometry

  2017cites this paper
• The chemical biology of HNO signaling.

  2017cites this paper
• Hydroxylamines With Organic-Based Leaving Groups as HNO Donors

  2017cites this paper
• From Heaven to Heart: Nitroxyl (HNO) in the Cardiovascular System and Beyond

  2017cites this paper
• A Phase 2a dose‐escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS‐986231 in hospitalized patients with heart failure with reduced ejection fraction

  2017cites this paper
• Mitochondrial Mechanosensor Microdomains in Cardiovascular Disorders.

  2017cites this paper
• Reaction-Based Fluorescent Probes for the Imaging of Nitroxyl (HNO) in Biological Systems.

  2017cites this paper
• The Reactions of HNO With Nonheme Proteins: An Emphasis on Thiol-Containing Proteins

  2017cites this paper
• The opposing roles of NO and oxidative stress in cardiovascular disease.

  2017cites this paper
• Modulación de la sincronización fótica del reloj circadiano en mamíferos

  2017cites this paper
• Cardioprotective effects of calcitonin gene-related peptide in isolated rat heart and in H9c2 cells via redox signaling.

  2017cites this paper
• Vasorelaxation to the Nitroxyl Donor Isopropylamine NONOate in Resistance Arteries Does Not Require Perivascular Calcitonin Gene–Related Peptide

  2017cites this paper
• Effects of Novel Anticancer Therapies on Cardiac Calcium Homeostasis

  2017cites this paper
• Two-photon red-emissive fluorescent probe for imaging nitroxyl (HNO) in living cells and tissues.

  2017cites this paper
• Nitroxyl donors for acute heart failure: promising newcomers

  2017cites this paper
• Altered Mitochondrial Metabolism and Mechanosensation in the Failing Heart: Focus on Intracellular Calcium Signaling

  2017cites this paper
• CXL-1020, a Novel Nitroxyl (HNO) Prodrug, Is More Effective than Milrinone in Models of Diastolic Dysfunction—A Cardiovascular Therapeutic: An Efficacy and Safety Study in the Rat

  2017cites this paper
• Ventricular Systolic Function

  2017cites this paper
• Development of N-Substituted Hydroxamic Acids with Pyrazolone Leaving Groups as Nitrosocarbonyl Precursors.

  2016cites this paper
• HNO suppresses LPS-induced inflammation in BV-2 microglial cells via inhibition of NF-κB and p38 MAPK pathways.

  2016cites this paper
• Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions—A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology

  2016cites this paper
• Nitrosocarbonyl release from O -substituted hydroxamic acids with pyrazolone leaving groups

  2016cites this paper
• Phosphine based fluorescent probes for nitroxyl detection and their reactivity toward S-nitrosothiols

  2016cites this paper
• The HNO donor Angeli's salt offers potential haemodynamic advantages over NO or dobutamine in ischaemia-reperfusion injury in the rat heart ex vivo.

  2016cites this paper
• HNO/Thiol Biology as a Therapeutic Target

  2016cites this paper
• Retracted: Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties

  2016cites this paper
• Bidirectional cross-regulation between ErbB2 and β-adrenergic signalling pathways.

  2016cites this paper
• Molecular and Integrative Physiological Effects of Isoflurane Anesthesia: The Paradigm of Cardiovascular Studies in Rodents using Magnetic Resonance Imaging

  2016influential citation
• Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure

  2016cites this paper
• Hypothesis: Clinical Symptoms of Iron Deficiency – Evidence of Functional Inability of Nitric Oxide Petukhov VI

  2016influential citation
• Nitroxyl (HNO) reduces endothelial and monocyte activation and promotes M2 macrophage polarization.

  2016cites this paper
• Photocontrol of NO, H2S, and HNO Release in Biological Systems by Using Specific Caged Compounds.

  2016cites this paper
• Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular System

  2015cites this paper
• Chronic Administration of the Nitroxyl Donor 1-Nitrosocyclo Hexyl Acetate Limits Left Ventricular Diastolic Dysfunction in a Mouse Model of Diabetes Mellitus In Vivo

  2015cites this paper
• Untersuchungen zu Struktur-Aktivitäts-Beziehungen am mARC-Enzymsystem

  2015cites this paper
• Nitroso-Redox Balance and Modulation of Basal Myocardial Function: An Update from the Italian Society of Cardiovascular Research (SIRC).

  2015cites this paper
• Impaired mitochondrial energy supply coupled to increased H2O2 emission under energy/redox stress leads to myocardial dysfunction during Type I diabetes.

  2015cites this paper
• "Catch-and-release" of HNO with pyrazolones.

  2015cites this paper
• Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties

  2015cites this paper
• A selective phosphine-based fluorescent probe for nitroxyl in living cells.

  2015cites this paper
• Mechanism(s) of ischaemia/reperfusion injury and cardioprotection

  2015influential citation
• Soluble Guanylate Cyclase Is Required for Systemic Vasodilation But Not Positive Inotropy Induced by Nitroxyl in the Mouse

  2015cites this paper
• Nitroxyl, a New Generation of Positive Inotropic Agent for Heart Failure

  2015cites this paper